Assessing liver fibrosis distribution through liver elasticity estimates obtained using a biomechanical model of respiratory motion with magnetic resonance elastography.

Authors:

Koya Fujimoto Takehiro Shiinoki Yuki Yuasa Yusuke Kawazoe Masatoshi Yamane Tatsuhiro Sera Hidekazu Tanaka

Phys Med Biol 2022 Jul 19;67(15). Epub 2022 Jul 19.

Department of Radiation Oncology, Graduate School of Medicine, Yamaguchi University 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8535, Japan.

. This study aimed to produce a three-dimensional liver elasticity map using the finite element method (FEM) and respiration-induced motion captured by T1-weighted magnetic resonance images (FEM-E-map) and to evaluate whether FEM-E-maps can be an imaging biomarker comparable to magnetic resonance elastography (MRE) for assessing the distribution and severity of liver fibrosis.. We enrolled 14 patients who underwent MRI and MRE. T1-weighted MR images were acquired during shallow inspiration and expiration breath-holding, and the displacement vector field (DVF) between two images was calculated using deformable image registration. FEM-E-maps were constructed using FEM and DVF. First, three Poisson's ratio settings (0.45, 0.49, and 0.499995) were validated and optimized to minimize the difference in liver elasticity between the FEM-E-map and MRE. Then, the whole and regional liver elasticity values estimated using FEM-E-maps were compared with those obtained from MRE using Pearson's correlation coefficients. Spearman rank correlations and chi-square histograms were used to compare the voxel-level elasticity distribution.. The optimal Poisson's ratio was 0.49. Whole liver elasticity estimated using FEM-E-maps was strongly correlated with that measured using MRE ( = 0.96). For regional liver elasticity, the correlation was 0.84 for the right lobe and 0.82 for the left lobe. Spearman analysis revealed a moderate correlation for the voxel-level elasticity distribution between FEM-E-maps and MRE (0.61 ± 0.10). The small chi-square distances between the two histograms (0.11 ± 0.07) indicated good agreement.. FEM-E-maps represent a potential imaging biomarker for visualizing the distribution of liver fibrosis using only T1-weighted images obtained with a common MR scanner, without any additional examination or special elastography equipment. However, additional studies including comparisons with biopsy findings are required to verify the reliability of this method for clinical application.

Download full-text PDF	Source
http://dx.doi.org/10.1088/1361-6560/ac7d35	DOI Listing

July 2022

Publication Analysis

Keyword Occurance

Similar Publications

Measurement of Liver Stiffness using Atomic Force Microscopy Coupled with Polarization Microscopy.

Authors:

Srikant Ojha Jan Pribyl Simon Klimovic Daniel Hadraba Marketa Jirouskova Martin Gregor

J Vis Exp 2022 Jul 20(185). Epub 2022 Jul 20.

Laboratory of Integrative Biology, Institute of Molecular Genetics of the Czech Academy of Sciences;

Matrix stiffening has been recognized as one of the key drivers of the progression of liver fibrosis. It has profound effects on various aspects of cell behavior such as cell function, differentiation, and motility. However, as these processes are not homogeneous throughout the whole organ, it has become increasingly important to understand changes in the mechanical properties of tissues on the cellular level. Read More

View Article and Full-Text PDF

July 2022

Similar Publications

Efficacy of shear wave elastography for the diagnosis of chronic pancreatitis.

Authors:

Hiroyuki Kojima Atsushi Sofuni Katsutoshi Sugimoto Takayoshi Tsuchiya Kentaro Ishii Reina Tanaka Ryosuke Tonozuka Kenjiro Yamamoto Noriyuki Hirakawa Takao Itoi

J Hepatobiliary Pancreat Sci 2022 Aug 2. Epub 2022 Aug 2.

Tokyo Medical University, Gastroenterology and Hepatology, 6-7-1, Nishishinjuku, Shinjukuku, Tokyo, Japan.

Background/purpose: Shear wave elastography (SWE) is a clinically method used to evaluate liver hardness. In this study, we assessed its applicability in assessing the pancreas and its potential for diagnosing chronic pancreatitis.

Methods: We performed SWE on 59 patients who underwent abdominal ultrasound, and measured the computed tomography (CT) values of the pancreas. Read More

View Article and Full-Text PDF

August 2022

Similar Publications

Comparing 2D-shear wave to transient elastography for the evaluation of liver fibrosis in nonalcoholic fatty liver disease.

Authors:

Dimitrios S Karagiannakis George Markakis Dimitra Lakiotaki Evangelos Cholongitas Jiannis Vlachogiannakos George Papatheodoridis

Eur J Gastroenterol Hepatol 2022 Sep 19;34(9):961-966. Epub 2022 Jul 19.

Academic Department of Gastroenterology.

Background And Aim: The aim of this study is to evaluate the performance of 2D-shear wave elastography (2D-SWE) in patients with nonalcoholic fatty liver disease (NAFLD) and compare it to transient elastography.

Methods: Over 6 months, 552 patients with NAFLD underwent liver stiffness measurement (LSM) by both 2D-SWE and transient elastography with controlled attenuation parameter (CAP) at the same visit.

Results: LSM was not feasible by transient elastography (M/XL probe) in 18 (3. Read More

View Article and Full-Text PDF

September 2022

Similar Publications

The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database.

Authors:

Naim Alkhouri Ashraf Almomani Phuc Le Julia Y Payne Imad Asaad Celine Sakkal Miriam Vos Mazen Noureddin Prabhat Kumar

BMC Gastroenterol 2022 Jul 30;22(1):366. Epub 2022 Jul 30.

Cleveland Clinic Foundation, Cleveland, OH, USA.

Background: The prevalence of fatty liver disease is potentially increasing in adolescents and young adults (AYAs) due to the obesity and alcohol pandemics. The aim of this study was to assess the prevalence of alcohol-associated fatty liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) in a representative U.S. Read More

View Article and Full-Text PDF

July 2022

Similar Publications

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.

BMC Public Health 2022 07 19;22(1):1385. Epub 2022 Jul 19.

Echosens, Paris, France.

Background: The development of liver cirrhosis is usually an asymptomatic process until late stages when complications occur. The potential reversibility of the disease is dependent on early diagnosis of liver fibrosis and timely targeted treatment. Recently, the use of non-invasive tools has been suggested for screening of liver fibrosis, especially in subjects with risk factors for chronic liver disease. Read More

View Article and Full-Text PDF

July 2022

Similar Publications

}

Search Our Scientific Publications & Authors